These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 18724391)

  • 41. [Treatment of nausea nad vomiting in palliative medicine].
    Bausewein C
    Z Arztl Fortbild Qualitatssich; 2000 Sep; 94(7):569-73. PubMed ID: 11048341
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemotherapy-induced nausea and vomiting in the treatment of gastrointestinal tumors and secondary prophylaxis with aprepitant.
    Abbrederis K; Lorenzen S; Rothling N; Ihbe-Heffinger A; Schuster T; Peschel C; Lordick F
    Onkologie; 2009 Feb; 32(1-2):30-4. PubMed ID: 19209016
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chemotherapy-induced nausea and vomiting: state of the art in 2006.
    Schwartzberg L
    J Support Oncol; 2006 Feb; 4(2 Suppl 1):3-8. PubMed ID: 16499138
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fosaprepitant: a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting.
    Navari RM
    Expert Rev Anticancer Ther; 2008 Nov; 8(11):1733-42. PubMed ID: 18983233
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [An antiemetic guideline for patients with malignancies in Japan].
    Takeuchi H; Saeki T
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):976-979. PubMed ID: 20567095
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practice.
    Hesketh PJ
    Oncologist; 1999; 4(3):191-6. PubMed ID: 10394587
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Chemotherapy induced-vomiting--a practical guide for prevention and therapy].
    Jordan K; Voigt W; Schmoll HJ
    Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1869-72. PubMed ID: 16915549
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Management of nausea, vomiting and anorexia due to anticancer agents].
    Shimada K; Taguchi S
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):760-4. PubMed ID: 12852341
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Outcomes of antiemetic prophylaxis in children undergoing bone marrow transplantation.
    Kusnierczyk NM; Saunders EF; Dupuis LL
    Bone Marrow Transplant; 2002 Jul; 30(2):119-24. PubMed ID: 12132051
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The use of navoban in the therapy of oncology patients with highly emetic treatments].
    Russel AJ
    Vopr Onkol; 1995; 41(1):87-90. PubMed ID: 7667952
    [No Abstract]   [Full Text] [Related]  

  • 51. International patterns of practice in the management of radiation therapy-induced nausea and vomiting.
    Dennis K; Zhang L; Lutz S; van Baardwijk A; van der Linden Y; Holt T; Arnalot PF; Lagrange JL; Maranzano E; Liu R; Wong KH; Wong LC; Vassiliou V; Corn BW; De Angelis C; Holden L; Wong CS; Chow E
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):e49-60. PubMed ID: 22704982
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanism of action of 5-HT3 receptor antagonists: clinical overview and nursing implications.
    Bremerkamp M
    Clin J Oncol Nurs; 2000; 4(5):201-7. PubMed ID: 11111451
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assuring the optimal use of serotonin antagonist antiemetics: the process for development and implementation of institutional antiemetic guidelines at Memorial Sloan-Kettering Cancer Center.
    Nolte MJ; Berkery R; Pizzo B; Baltzer L; Grossano D; Lucarelli CD; Kris MG
    J Clin Oncol; 1998 Feb; 16(2):771-8. PubMed ID: 9469369
    [TBL] [Abstract][Full Text] [Related]  

  • 54. History of the development of antiemetic guidelines at Mayo Clinic Rochester.
    Loprinzi CL; Alberts SR; Christensen BJ; Hanson LJ; Farley DR; Broers JK; Betcher DL; Grady RE; Southorn PA; Johnson TM; Perez EA
    Mayo Clin Proc; 2000 Mar; 75(3):303-9. PubMed ID: 10725961
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Casopitant: a new warrior in the antiemetic crusade.
    Khojasteh A; Khojasteh A; Thornburg BG; Maher KR
    Expert Opin Pharmacother; 2009 Jun; 10(8):1367-76. PubMed ID: 19445564
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A survey of antiemetic use in children with cancer.
    van Hoff J; Hockenberry-Eaton MJ; Patterson K; Hutter JJ
    Am J Dis Child; 1991 Jul; 145(7):773-8. PubMed ID: 2058609
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antiemetic therapy.
    Axelrod RS
    Compr Ther; 1997 Aug; 23(8):539-45. PubMed ID: 9283743
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Consensus regarding multiple day and rescue antiemetic therapy.
    De Mulder PH; Roila F; Kris MG; Marty MM
    Support Care Cancer; 1998 May; 6(3):248-52. PubMed ID: 9629878
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment implications for radiation-induced nausea and vomiting in specific patient groups.
    Horiot JC; Aapro M
    Eur J Cancer; 2004 May; 40(7):979-87. PubMed ID: 15093572
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The importance of simple, easy-to-follow antiemetic guidelines.
    Feyer P
    Acta Oncol; 2004 Sep; 43 Suppl 15():5-8. PubMed ID: 15370623
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.